Japan Cancer Diagnostics Market Size & Outlook, 2023-2030
Japan cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Japan cancer diagnostics market highlights
- The Japan cancer diagnostics market generated a revenue of USD 5,532.8 million in 2023 and is expected to reach USD 8,808.3 million by 2030.
- The Japan market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 5,532.8 million |
| Market revenue in 2030 | USD 8,808.3 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 5.1% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,680.0 million by 2030.
Consumables was the largest segment with a revenue share of 59.99% in 2023. Horizon Databook has segmented the Japan cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is one of the most advanced countries in this region, and its market is expected to grow rapidly, owing to high government spending to curb cancer prevalence. The increase in cancer prevalence can be attributed to rapid growth in the geriatric population.
Japan has a median age of 44 years, one of the highest in the world. In contrast to other Asia Pacific countries, Japan offers country-wide cancer screening programs to combat its growing prevalence. This program offers cancer screening to over 94% of the population.
However, stringent policies by regulatory agencies may delay the introduction of newer technologies in the market, which may hamper market growth during the forecast period. AI Medical Service, a Tokyo-based startup, is developing an AI-based endoscopic diagnostic support system, believing in AI’s capabilities to enhance medical outcomes.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan cancer diagnostics market size, by product, 2018-2030 (US$M)
Japan Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
